List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Tinnitus - Overview
Tinnitus - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Tinnitus - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Tinnitus - Companies Involved in Therapeutics Development
AudioCure Pharma GmbH
Auris Medical Holding Ltd
Autifony Therapeutics Ltd
Cognosetta Inc
Gateway Biotechnology Inc
Knopp Biosciences LLC
Otonomy Inc
Sensorion SA
Tinnitus - Drug Profiles
AC-102 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AM-102 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AUT-3 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs for Tinnitus - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
gacyclidine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GW-103 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GW-201 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KB-3061 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptides to Target Calcium Activated Potassium Channel for Tinnitus - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RL-81 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Activate KCNQ2 and KCNQ3 for Tinnitus - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit TNF-Alpha for Tinnitus - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Target Calcium Activated Potassium Channel for Tinnitus - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Tinnitus - Dormant Projects
Tinnitus - Discontinued Products
Tinnitus - Product Development Milestones
Featured News & Press Releases
Jul 06, 2020: Otonomy reports positive top-line results from phase 1/2 clinical trial of OTO-313 in patients with tinnitus
Jan 10, 2020: Auris Medical announces notice of allowance for European Patent Application
Apr 11, 2019: Otonomy initiates phase 1/2 Clinical Trial of OTO-313 in Tinnitus
Feb 06, 2019: Otonomy announces presentation on tinnitus drug OTO-313 at Association for Research in Otolaryngology Annual Meeting
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Tinnitus, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Tinnitus - Pipeline by AudioCure Pharma GmbH, H2 2020
Tinnitus - Pipeline by Auris Medical Holding Ltd, H2 2020
Tinnitus - Pipeline by Autifony Therapeutics Ltd, H2 2020
Tinnitus - Pipeline by Cognosetta Inc, H2 2020
Tinnitus - Pipeline by Gateway Biotechnology Inc, H2 2020
Tinnitus - Pipeline by Knopp Biosciences LLC, H2 2020
Tinnitus - Pipeline by Otonomy Inc, H2 2020
Tinnitus - Pipeline by Sensorion SA, H2 2020
Tinnitus - Dormant Projects, H2 2020
Tinnitus - Discontinued Products, H2 2020

List of Figures
Number of Products under Development for Tinnitus, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020

Companies Mentioned
• AudioCure Pharma GmbH
• Auris Medical Holding Ltd
• Autifony Therapeutics Ltd
• Cognosetta Inc
• Gateway Biotechnology Inc
• Knopp Biosciences LLC
• Otonomy Inc
• Sensorion SA